Titus Wouda-Kuipers, Board Mentor, Criticaleye

Titus Wouda-Kuipers

Board Mentor


Titus is a Board Member at Lorea AG, a diversified industrial holding company which invests equity capital from entrepreneurs and family businesses. He is also Founder and Chair of Vilosophy, a start-up FMCG company.

Titus consults with businesses on strategy, especially in the area of transformation and growth. Over the past 10 years, he has been an active Board Member, gaining non-executive experience in consultancy firms (M&A and purchasing) and a consumer packaged goods firm.

Titus has held FTSE 350 executive committee posts and has over 20 years' experience in the sales and marketing of consumer goods, manufacturing and start-up/scale-up emerging businesses. Strategic oversight, performance management, stakeholder engagement and corporate governance, especially in the context of regulation compliance, are his areas of expertise.

Titus was CEO of Fontem Ventures, a fast-growth, consumer goods business set up as a subsidiary of Imperial Brands Plc. He oversaw exponential revenue growth for this business via operational re-organisation, innovation, growth by acquisition and extension of market footprint.

Prior to this, as Global Operations Director for Imperial Brands plc, Titus was responsible for restructuring the global footprint of 47 manufacturing sites and a total of 17,000 employees. He held the P&L responsibility for the largest EBITDA region of Imperial (Europe, Australasia, Caucasus). He has extensive experience in leading teams, change processes, M&A, lean management, innovation and product development.

Titus lives in Hamburg, Germany, but travels to London frequently. He holds an MBA from the University of Groningen in the Netherlands.

Royal London Group LDC Robert Walters Redwood Bank Eton Bridge Partners Cognizant Lightsource bp Bunzl plc Google Drax Group plc Mayborn Group EY Hong Kong Amazon UK Accenture Veolia Water Technologies Jamieson Corporate Finance E.ON UK AntWorks Tullow Oil plc London Stock Exchange Legal & General Investment Management GlaxoSmithKline plc Workday